AUPP154298A0 - Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation - Google Patents

Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Info

Publication number
AUPP154298A0
AUPP154298A0 AUPP1542A AUPP154298A AUPP154298A0 AU PP154298 A0 AUPP154298 A0 AU PP154298A0 AU PP1542 A AUPP1542 A AU PP1542A AU PP154298 A AUPP154298 A AU PP154298A AU PP154298 A0 AUPP154298 A0 AU PP154298A0
Authority
AU
Australia
Prior art keywords
hepatic
oxygenation
reversal
aging
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP1542A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Le Couteur David George
Original Assignee
Le Couteur D G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le Couteur D G filed Critical Le Couteur D G
Priority to AUPP1542A priority Critical patent/AUPP154298A0/en
Publication of AUPP154298A0 publication Critical patent/AUPP154298A0/en
Priority to AU22599/99A priority patent/AU2259999A/en
Priority to PCT/AU1999/000065 priority patent/WO1999038507A1/en
Abandoned legal-status Critical Current

Links

AUPP1542A 1998-01-30 1998-01-30 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation Abandoned AUPP154298A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP1542A AUPP154298A0 (en) 1998-01-30 1998-01-30 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AU22599/99A AU2259999A (en) 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
PCT/AU1999/000065 WO1999038507A1 (en) 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP1542A AUPP154298A0 (en) 1998-01-30 1998-01-30 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Publications (1)

Publication Number Publication Date
AUPP154298A0 true AUPP154298A0 (en) 1998-02-19

Family

ID=3805819

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP1542A Abandoned AUPP154298A0 (en) 1998-01-30 1998-01-30 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Country Status (1)

Country Link
AU (1) AUPP154298A0 (en)

Similar Documents

Publication Publication Date Title
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
AU1606900A (en) Non-electrolytic gold plating compositions and methods of use thereof
AU1920900A (en) Solid water treatment composition and methods of preparation and use
PL342892A1 (en) Remineralization of teeth
HUP0002493A3 (en) Use of colchinol derivatives as vascular damaging agents and certain new compounds
EP1076547A4 (en) Derivatives of arabinogalactan and compositions including the same
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
AU3118499A (en) Soft tissue reconstructor and method of use
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
IL138672A0 (en) Liposomal bupivacaine compositions and methods of preparation
AU3671999A (en) Combination of main scrubbing machine and attachment scrubbing machine
AU7277798A (en) Use of sialyl galactosides and related compounds as anti-angiogenic agents
AU6412599A (en) Oxybutynin formulations and methods of use
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
AU2259999A (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP154298A0 (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP770198A0 (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AUPP761998A0 (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AU6593100A (en) Interdental brush and interdental brush set
AU3964499A (en) Agouti-related protein analogs and methods of use
AU5226798A (en) Use of paracetamol as depigmenting agent
AU3774100A (en) Heat-activated cleaning compositions with wrinkle-resistance and methods of use
TW406556U (en) Improvement of dental floss structure
AU4207899A (en) Lentiviral vector compositions and methods of use